Peroxisome Proliferator-Activated Receptor α Agonists Increase Nitric Oxide Synthase Expression in Vascular Endothelial Cells
- 1 April 2004
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 24 (4), 658-663
- https://doi.org/10.1161/01.atv.0000118682.58708.78
Abstract
Objective— There has been accumulating evidence demonstrating that activators for peroxisome proliferator-activated receptor α (PPARα) have antiinflammatory, antiatherogenic, and vasodilatory effects. We hypothesized that PPARα activators can modulate endothelial nitric oxide synthase (eNOS) expression and its activity in cultured vascular endothelial cells. Methods and Results— Bovine aortic endothelial cells were treated with the PPARα activator fenofibrate. The amount of eNOS activity and the expression of eNOS protein and its mRNA were determined. Our data show that treatment with fenofibrate for 48 hours resulted in an increase in eNOS activity. Fenofibrate failed to increase eNOS activity within 1 hour. Fenofibrate also increased eNOS protein as well as its mRNA levels. RU486, which has been shown to antagonize PPARα action, inhibited the fenofibrate-induced upregulation of eNOS protein expression. WY14643 and bezafibrate also increased eNOS protein levels, whereas rosiglitazone did not. Transient transfection experiments using human eNOS promoter construct showed that fenofibrate failed to enhance eNOS promoter activity. Actinomycin D studies demonstrated that the half-life of eNOS mRNA increased with fenofibrate treatment. Conclusions— PPARα activators upregulate eNOS expression, mainly through mechanisms of stabilizing eNOS mRNA. This is a new observation to explain one of the mechanisms of PPARα-mediated cardiovascular protection.Keywords
This publication has 37 references indexed in Scilit:
- Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells.JCI Insight, 1998
- Expression of Peroxisome Proliferator-Activated Receptor α (PPARα) in Primary Cultures of Human Vascular Endothelial CellsBiochemical and Biophysical Research Communications, 1998
- Micronised FenofibrateDrugs, 1997
- Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor.JCI Insight, 1995
- Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions.Hypertension, 1994
- ENDOTHELIAL-LEUKOCYTE ADHESION MOLECULES IN HUMAN DISEASEAnnual Review of Medicine, 1994
- Interleukin 6 gene transcripts are expressed in human atherosclerotic lesionsCytokine, 1994
- IL‐6 and NF‐IL6 in Acute‐Phase Response and Viral InfectionImmunological Reviews, 1992
- Interleukin 6 gene transcripts are expressed in atherosclerotic lesions of genetically hyperlipidemic rabbitsAtherosclerosis, 1992
- Endothelin stimulates c‐fos and c‐myc expression and proliferation of vascular smooth muscle cellsFEBS Letters, 1988